Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEO

Brian Longstreet appointed as Chief Executive Officer to Lead Company Through Phase 2/3 Development and Commercialization NEW YORK, July 14, 2026 /PRNewswire/ -- Illuminare Biotechnologies, a clinical-stage company pioneering novel imaging agents to improve intraoperative nerve...